SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release firs…
Author: Business Wire
Katena Products Announces the Acquisition of ASICO, LLC.
PARSIPPANY, N.J.–(BUSINESS WIRE)–Katena Products, Inc. (Katena) a leading global provider of premium ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of ASICO,…
Aura Biosciences Announces Publication of Data in Cancer Immunology Research, Supporting the Immune Mediated Mechanism of Action of the Virus-Like Drug Conjugate (VDC) Technology Platform with Broad Application in Cancer Treatment
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the online publication of data in the peer-r…
Kopin To Participate in New Webinar Series – AR and VR: The Paradigm Shift to Smartglasses Starts Now
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin® Corporation (NASDAQ: KOPN), a leading developer and provider of transmissive and reflective active matrix liquid crystal and organic light emitting diode (OLED) microdisplays used in military, enterprise, ind…
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
MARIETTA, Ohio–(BUSINESS WIRE)—- $PKTX #AAGP–ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
AmeriHealth Caritas Selected to Serve Ohio’s Medicaid and CHIP Populations
PHILADELPHIA–(BUSINESS WIRE)– #Medicaid–AmeriHealth Caritas has been selected by Ohio Department of Medicaid to serve Ohio’s Medicaid managed care program.
2021 Global Ophthalmic Lasers Market Analysis and Forecast Model with COVID-19 Impact – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Lasers (Ophthalmic Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)” report has been added to ResearchAndMarkets.com’s offering. This report was built to visualize quantitative marke…
Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today …
Worldwide Allergic Conjunctivitis Industry to 2027 – by Countries, Disease Type, Pipeline Drugs and Company Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Conjunctivitis Market, Global Forecast Treated Patients By Countries, Disease Type, Pipeline Drugs, Company Analysis” report has been added to ResearchAndMarkets.com’s offering. According to this report the allerg…
Global Eyewear Market Report to 2026 – Trends, Forecast and Competitive Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear Market Report: Trends, Forecast and Competitive Analysis” report has been added to ResearchAndMarkets.com’s offering. The future of the global eyewear market looks promising with opportunities in the online and off…
Outlook on the Corneal Topographers Global Market to 2025 – Competitive Analysis and Impact of COVID-19 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Corneal Topographers Market (2020-2025) by Product, Application, Technology, End-User, Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offer…
Where Consumers Shop for Eyewear, 2021 Report – Impact of Coronavirus / Channel Shifts / Store-based Channels / Non-store Channels – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Where Consumers Shop for Eyewear” report has been added to ResearchAndMarkets.com’s offering. The Where Consumers Shop for Eyewear global briefing offers detailed strategic analysis of the global Eyewear market by pinpoint…
Digital Vision Syndrome: A Growing Public Health Concern
COPPELL, Texas–(BUSINESS WIRE)–Nearly 65 percent of U.S. adults complain of headaches, neck and shoulder pain and eye strain when using digital devices, reading or doing detail work, according to a study from neurolens, the maker of the world’s first…
Global Glaucoma Eye Drops Market to Surpass US$ 2,182.3 Million by 2027, Says Coherent Market Insights (CMI)
SEATTLE–(BUSINESS WIRE)– #AlphaAgonists–North America is expected to witness significant growth of the market, owing to increasing product launches and approvals of glaucoma eye drops.
Presbyopia Epidemiology Forecast to 2030 – Focus on United States, Japan, Germany, Italy, France, United Kingdom, and Spain – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Presbyopia – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Presbyopia – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical…
Aerie Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
Esya Labs Provides Novel Research Assays to Accelerate Drug Discovery Efforts
CHICAGO–(BUSINESS WIRE)– #Diagnostics–Esya Labs, which is developing ground-breaking novel research assays, has announced that Novartis is among the first companies to use its technology.
Second Sight Medical Products Names Dean Baker and Alexandra Larson to its Board of Directors
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for b…
France Relance : Aryballe obtient 1,1 millions d’euros pour intensifier ses innovations industrielles en olfaction digitale
GRENOBLE, France–(BUSINESS WIRE)–Aryballe obtient 1,1 millions d’euros pour intensifier ses innovations industrielles en olfaction digitale.
New UPLIZNA® (inebilizumab-cdon) Data in People With Neuromyelitis Optica Spectrum Disorder (NMOSD) to be Presented at the American Academy of Neurology’s 73rd Annual Meeting
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics announces new NMOSD data being presented at the American Academy of Neurology’s 73rd Annual Meeting.